Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Harvard Apparatus Regenerative Technology (HRGN) Stock Price & Analysis

HRGN Stock Chart & Stats

$2.30$0.14(6.48%)
At close: 4:00 PM EDT
$1$1.5$23 Aug17 Aug1 Sep15 Sep28 Sep12 Oct27 Oct
Day’s Range
$1.97 - $2.30
52-Week Range
$0.96 - $2.46
Previous Close
$2.16
Volume
1,207
Average Volume (3M)
1,393
Market Cap
$46.65M
Enterprise Value
$18.57T
Total Cash (Recent Filing)
$351.00K
Total Debt (Recent Filing)
$645.00K
Price to Earnings (P/E)
―
Beta
-0.11
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth

The sharp improvement in TTM revenue indicates that the company is generating more commercial activity than in prior periods. If this momentum persists, a larger revenue base could improve operating leverage and help the business absorb its currently heavy fixed cost structure.

Fresh Equity Capital

The completed equity financing adds capital to support ongoing operations and gives the company additional financial flexibility over the next several months. Access to fresh equity is important because the business is still cash-flow negative and requires funding while it works toward greater commercial scale.

Debt Conversion And Insider Alignment

Converting bridge notes into shares removes a short-term obligation and modestly strengthens the capital structure without requiring repayment in cash. The transaction also aligns the CEO’s economic exposure more closely with shareholders, potentially supporting a longer-term focus on business value creation.

Bears Say

Severe Unprofitability

The company is producing losses that are extremely large relative to its revenue, with even gross profit remaining negative. This shows that the current operating model has not reached economic viability, and substantial improvement in pricing, costs, or scale is needed before revenue growth can translate into durable earnings.

Persistent Cash Burn

Negative operating and free cash flow indicate that reported losses are translating into ongoing cash outflows rather than being mainly non-cash accounting effects. Continued burn increases dependence on external funding and can restrict the company’s ability to invest in growth or withstand operating setbacks.

Negative Equity And Balance-Sheet Deterioration

The move into negative equity materially weakens financial resilience even though absolute debt remains relatively low. Shrinking assets and a deficit capital base reduce flexibility, increase funding pressure, and leave the company more dependent on successful financings to sustain operations.

Harvard Apparatus Regenerative Technology News

HRGN FAQ

What was Harvard Apparatus Regenerative Technology’s price range in the past 12 months?
Harvard Apparatus Regenerative Technology lowest stock price was $0.96 and its highest was $2.46 in the past 12 months.
What is Harvard Apparatus Regenerative Technology’s market cap?
Harvard Apparatus Regenerative Technology’s market cap is $46.65M.
When is Harvard Apparatus Regenerative Technology’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Harvard Apparatus Regenerative Technology’s earnings last quarter?
Harvard Apparatus Regenerative Technology released its earnings results on May 18, 2026. The company reported -$0.091 earnings per share for the quarter.
Is Harvard Apparatus Regenerative Technology overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Harvard Apparatus Regenerative Technology pay dividends?
Harvard Apparatus Regenerative Technology does not currently pay dividends.
What is Harvard Apparatus Regenerative Technology’s EPS estimate?
Harvard Apparatus Regenerative Technology’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Harvard Apparatus Regenerative Technology have?
Harvard Apparatus Regenerative Technology has 20,284,472 shares outstanding.
What happened to Harvard Apparatus Regenerative Technology’s price movement after its last earnings report?
Harvard Apparatus Regenerative Technology reported an EPS of -$0.091 in its last earnings report. Following the earnings report the stock price went down -5.405%.
Which hedge fund is a major shareholder of Harvard Apparatus Regenerative Technology?
Currently, no hedge funds are holding shares in HRGN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology